Mortality or bust: what makes for a meaningful VT trial outcome?
Stevenson, William
(
Vanderbilt University Medical Ctr
, Nashville , Tennessee , United States )
Gerstenfeld, Edward
(
UCSF
, SanFrancisco , California , United States )
Author Disclosures:
William Stevenson:DO have relevant financial relationships
;
Other (please indicate in the box next to the company name):abbott speaking honoria:Active (exists now)
; Researcher:Adagio:Active (exists now)
; Other (please indicate in the box next to the company name):Mediasphere- speaking honoria:Active (exists now)
; Other (please indicate in the box next to the company name):Biotronik speaking honoria:Past (completed)
; Other (please indicate in the box next to the company name):Boston Scientific - speaking honoria:Active (exists now)
; Other (please indicate in the box next to the company name):JOhnson and Johnson - speaking honoria:Active (exists now)
| Edward GERSTENFELD:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Abbott:Past (completed)
; Consultant:Adagio Medical:Past (completed)
; Consultant:Medtronic:Active (exists now)
; Consultant:Biosense-Webster:Active (exists now)
; Consultant:Boston Scientific:Active (exists now)
; Consultant:Abbott:Active (exists now)